OneSource Specialty Pharma Inc Stock Price Today (NSE: ONESOURCE)

OneSource Specialty Pharma Inc

1617.10+17.20 (+1.08%)
Market Open

Fundamental Score

...

OneSource Specialty Pharma Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis

OneSource Specialty Pharma Inc share price today is 1617.10, up +1.08% on NSE/BSE as of 17 June 2026. OneSource Specialty Pharma Inc (ONESOURCE) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of 18.39K (Cr). The 52-week high for ONESOURCE share price is 2248.00 and the 52-week low is 1057.00. At a P/E ratio of 133.33x, ONESOURCE is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 3.34% and a debt-to-equity ratio of 0.22.

OneSource Specialty Pharma Inc Share Price Chart — NSE/BSE Historical Performance

No data
High
1917.80
Low
1617.10
Volume
2.9L
Change
-2.68%

OneSource Specialty Pharma Inc share price chart: -2.68% return over the past month. 52-week high ₹2248.00, 52-week low ₹1057.00.

OneSource Specialty Pharma Inc — Last 10 Trading Days

DateOpenHighLowCloseVolume
1820.001847.801775.001828.603.64L (Cr)
1793.001884.001791.001837.804.06L (Cr)
1791.101888.401771.601824.606.05L (Cr)
1821.901821.901760.401791.101.55L (Cr)
1800.001823.901773.001805.601.81L (Cr)
1826.001844.501780.201806.802.97L (Cr)
1861.801873.901821.001834.501.18L (Cr)
1888.001888.001842.201861.801.52L (Cr)
1848.001905.001831.501867.402.69L (Cr)
1810.001871.001810.001854.501.50L (Cr)

OneSource Specialty Pharma Inc — Last 12 Months Price History

MonthOpenHighLowCloseChange
1793.001884.001775.001828.60+1.99%
1774.001917.801704.701824.60+2.85%
1480.701870.001316.401738.10+17.38%
1289.601542.801231.001473.30+14.24%
1200.001395.801102.001346.80+12.23%
1809.001809.001057.001194.50-33.97%
1536.001824.001515.201810.60+17.88%
1854.101925.001494.701532.20-17.36%
1823.001896.701775.001854.10+1.71%
1891.001921.901681.401840.40-2.68%
1960.001964.301792.401892.20-3.46%
2201.302231.901930.101974.00-10.33%

Returns & Performance

Poor

Return on Equity (ROE)

3.34%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

5.52%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

8.21%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

OneSource Specialty Pharma Inc Valuation Check

Poor

Price to Earnings (P/E)

133.33x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.77x

Average P/E of all peers in this sector

Market-cap Classification
Mid-cap
Balance of growth potential and stability.

Shareholding Pattern

Excellent

Promoter Holding

29.77%

% shares held by company founders/management

Good

FII Holding

19.39%

% shares held by foreign institutional investors

Good

DII Holding

18.48%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

26.04%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

127.55%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

12.49%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.22x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

1.87x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-1.97K (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

OneSource Specialty Pharma Inc Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ONESOURCE across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Robust Profit Growth (127.55%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Conservative Debt Levels (D/E: 0.22)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Institutional Confidence (FII+DII: 37.87%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Risk Factors

8 factors identified

Below-Average Return on Equity (3.34%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (5.52%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Premium Valuation Risk (P/E: 133.33x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Weak Interest Coverage (1.87x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-1969.92 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (29.77%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

High Share Pledging Risk (26.04%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

OneSource Specialty Pharma Inc vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare OneSource Specialty Pharma Inc with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
5.5/100
1617
₹18392.12
133.3
Average
3.34%
Poor
5.52%
Poor
0.2
Excellent
0.00%
65.2/100
1882
₹433738.68
37.6
Average
16.86%
Good
20.21%
Excellent
0.1
Excellent
23.78%
Excellent
9.87%
Good
0.89%
67.9/100
6798
₹170445.88
68.6
Average
15.35%
Good
20.44%
Excellent
0.0
Excellent
10.41%
Good
11.65%
Good
0.47%
65.3/100
4460
₹126430.62
58.4
Average
26.52%
Excellent
27.05%
Excellent
0.3
Excellent
13.84%
Good
7.72%
Good
0.86%
Cipla Ltd...
CIPLA500087
59/100
1418
₹123059.76
22.6
Average
17.77%
Good
22.72%
Excellent
0.0
Excellent
28.68%
Excellent
9.97%
Good
0.85%
59.2/100
1335
₹105224.96
18.2
Average
17.96%
Good
22.69%
Excellent
0.2
Excellent
22.28%
Excellent
13.26%
Good
0.63%
Lupin Ltd...
LUPIN500257
66.7/100
2287
₹95148.15
22.0
Average
20.62%
Excellent
21.30%
Excellent
0.3
Excellent
54.88%
Excellent
8.11%
Good
0.58%
68.7/100
957
₹94253.78
18.7
Average
21.21%
Excellent
24.31%
Excellent
0.4
Excellent
25.92%
Excellent
10.27%
Good
1.17%
50.6/100
2493
₹92012.53
52.6
Average
14.68%
Average
15.98%
Good
0.6
Good
11.73%
Good
15.79%
Excellent
0.04%
28.8/100
1436
₹70798.69
20.7
Average
11.08%
Average
14.18%
Average
0.2
Excellent
3.87%
Average
6.55%
Good
0.33%
59.5/100
5452
₹67075.29
28.5
Average
19.39%
Good
20.38%
Excellent
0.2
Excellent
13.93%
Good
9.21%
Good
0.80%

OneSource Specialty Pharma Inc Quarterly Performance

Latest quarterly metrics for ONESOURCE — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

12.49%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

127.55%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

OneSource Specialty Pharma Inc Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ONESOURCE — calculated from daily price history

46RSI 14
Neutral — RSI 46

Momentum is balanced — neither overbought nor oversold.

SMA 50
1625
▼ Price below SMA 50 — Short-term bearish
SMA 200
1662
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
628K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

OneSource Specialty Pharma Inc Financial Statements

Annual income statement, balance sheet and cash flow for OneSource Specialty Pharma Inc (ONESOURCE) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for OneSource Specialty Pharma Inc

About ONESOURCE (OneSource Specialty Pharma Inc)

OneSource Specialty Pharma Inc. is a dynamic pharmaceutical company dedicated to innovating and improving patient lives through specialized drug development and commercialization. ...Focused on niche therapeutic areas, OneSource concentrates its efforts on creating targeted solutions for complex medical conditions where unmet needs persist. Their approach emphasizes rigorous scientific research, cutting-edge formulation technologies, and strategic partnerships to bring high-quality, effective medications to market. The company operates with a commitment to ethical practices and prioritizes patient safety and well-being in every aspect of its operations. OneSource distinguishes itself within the pharmaceutical landscape by integrating research and development with advanced manufacturing capabilities. This synergy allows for streamlined product development cycles, ensuring efficient progression from laboratory to patient. The company's state-of-the-art facilities are equipped to handle a diverse range of dosage forms and delivery systems, including both oral and injectable medications. Furthermore, OneSource actively seeks collaborations with academic institutions and other pharmaceutical companies to leverage expertise and accelerate the discovery and development of novel therapies. Driven by a team of experienced scientists, clinicians, and business professionals, OneSource is committed to expanding its product portfolio and geographic reach. The company's strategic vision involves identifying and capitalizing on emerging market opportunities, while maintaining a steadfast dedication to scientific rigor and patient-centric values. As OneSource continues to grow, it remains dedicated to making a meaningful impact on global healthcare by providing innovative, specialized pharmaceuticals that improve patient outcomes and enhance the quality of life.

Company Details

Symbol:ONESOURCE
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Neeraj Sharma
CEO, MD & Director
Mr. Anurag Bhagania
Chief Financial Officer
Ms. Allada Trisha
Company Secretary & Compliance officer

ONESOURCE Share Price: Frequently Asked Questions

What is the current share price of OneSource Specialty Pharma Inc?

OneSource Specialty Pharma Inc (ONESOURCE) trades at ₹1617.10 on NSE and BSE. Market cap ₹18.39K (Cr). Educational data only.

What is the P/E ratio of OneSource Specialty Pharma Inc?

OneSource Specialty Pharma Inc has a P/E of 133.33x vs industry average 31.77x.

What is the Bull Run score for OneSource Specialty Pharma Inc?

OneSource Specialty Pharma Inc has a Bull Run score of 5.5/100 based on 25+ financial parameters.

Does OneSource Specialty Pharma Inc pay dividends?

OneSource Specialty Pharma Inc has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of OneSource Specialty Pharma Inc?

OneSource Specialty Pharma Inc has ROE of 3.34%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of OneSource Specialty Pharma Inc?

OneSource Specialty Pharma Inc has debt-to-equity of 0.22.

Is OneSource Specialty Pharma Inc a good investment?

Bull Run gives OneSource Specialty Pharma Inc a score of 5.5/100. This is not investment advice — consult a SEBI-registered advisor.